Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

Astellas

Status: Completed

Conditions: Castration-resistant Prostate Cancer

Treatments: Drug: enzalutamide

Study type: Observational

Funder types: Industry

Identifiers

NCT02669771

9785-MA-1018

Details and patient eligibility

About

The purpose of this study is to confirm the long term safety and efficacy of enzalutamide in patients.

Enrollment: 1,018 patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

• no history of treatment with enzalutamide

Exclusion criteria

Trial design

1,018 participants in 1 patient group

Enzalutamide group

Description:

oral

Treatment:

Drug: enzalutamide